MYLAN DA 15 MYLAN DA 15 (Dextroamphetamine Sulfate Extended-Release 15 mg)
Pill with imprint MYLAN DA 15 MYLAN DA 15 is Brown & White, Capsule-shape and has been identified as Dextroamphetamine Sulfate Extended-Release 15 mg. It is supplied by Mylan Pharmaceuticals Inc..
Dextroamphetamine is used in the treatment of adhd; narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for MYLAN DA 15 MYLAN DA 15
Dextroamphetamine Sulfate Extended-Release
- Imprint
- MYLAN DA 15 MYLAN DA 15
- Strength
- 15 mg
- Color
- Brown & White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1072
- Inactive Ingredients
-
ferrosoferric oxide, corn starch, hypromelloses, ferric oxide red, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide, ferric oxide yellow, ammonia, propylene glycol, shellac
Note: Inactive ingredients may vary.
More about dextroamphetamine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 182 Reviews
- Drug class: CNS stimulants
- FDA Alerts (2)
Consumer resources
- Dextroamphetamine
- Dextroamphetamine Sustained-Release Capsules
- Dextroamphetamine Tablets
- Dextroamphetamine Oral Solution
- Dextroamphetamine (Advanced Reading)
Other brands: Dexedrine, Zenzedi, ProCentra, Dextrostat, Liquadd
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
